| Tag | Content |
|---|
EnhancerAtlas ID | HS127-20969 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr3:20101790-20103660 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CEBPA | MA0102.3 | chr3:20102545-20102556 | TATTGTGCAAT | - | 6.62 | | Foxd3 | MA0041.1 | chr3:20102094-20102106 | AAACAAACAAAC | - | 6.32 | | Foxd3 | MA0041.1 | chr3:20102098-20102110 | AAACAAACAAAC | - | 6.32 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_19534 | chr3:20102124-20103236 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_54124 | chr3:20102262-20102950 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr3 | 20102512 | 20102922 | | chr3 | 20102324 | 20102436 | | chr3 | 20102910 | 20103147 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I020060 | chr3 | 20102059 | 20103292 |
|
Enhancer Sequence | GTTGTTTCTT AAAAAACTGT GGGCTGGGCA TGGTGGCTCA CGCCTGTAGT CCCAGTACTT 60
TGGGAGGCCA AGGCGGGCGG ATCACCTGAG GTCGGGAGTC TGAGACCAAC CTGACCAACA 120
GGGAGAAACC CTGTCTCTAC TAAAAATACA AAATTAGCTG GGCATGGTGG TGCATGCCTG 180
TAATCCCAGC TACTGGGGAG GCTGAGGCAG GAGAATCTCT TAAACCCAGG AGGCGGAGGT 240
TGCAGTGAGC TGAGATCACG CCATTGCACT CCAGCCTGGG CAACAAGAGA GAAACTCTGT 300
CTAAAAACAA ACAAACAAAC ACACAAACAA CAAACTGTGG TAATGCTGGG CATGGTAGCT 360
CATGGCCTGT AATCTTAGTA CTTTGGGAGG CTGAGGTGGG AAGATCCCTT GAGTCCAGGA 420
GTTTGAGACC AGCGTGAGTA ACATAGTAAG ACCCTGTCTC TACCAAAAAA TAAAAATAAA 480
AAATAAAATA AAATAAATTA TCCAGGTGTA GAGGTACATG CCTGTGGTCC TGTCTACTCA 540
GGAGGCTGAA GTTGGAGGAT TGCTTGAACC CAGGAGGTTG AGGTTGTAAT AAACCATGAT 600
CATGCCACTG CACTCCTGGG CAACAGAGTG AGACCCTGTC TCAAAACAAC AACAACAACA 660
ACAACAACAA AACTGTGGTA AAATATAGAT GATCTAAAGT TTACCATCTG AACTATTTTT 720
AAGTGTCTAG TTCATTGGTA TTAAGAAATT CACATTATTG TGCAATCATC ACCACCATTC 780
ATCCACAGAA CACTTTTCAG CTTGCAAAAC TGAAACTCTG TGTTCATTAA ACAGTAACTC 840
CCTCTTCCTT CCTCCAACCC CTCGGCAACC ACCATTCCTA TCTCTATGAA TTTGGCTACC 900
ATAGACACCT TATCTAAGTG GAATCATACA GTATTTGTCA TTTTGTGACT ATTTTACTTA 960
GCATAACATT CTCAAGTTTC ATTCAGGTTG TGGCATGTGT CAGAGTTGCC TTTCTTTTTA 1020
AGGTTATATA ATAGCCCTTT GAATGTATAT ACTACGTTTT ACTTATTTAT TCATCTCTTA 1080
AGGGATGCTG GGGTTGCTTG GACCTTCTTG CTGTTGTGCT TAATAATGAT ACTAGGACAT 1140
GGGTGTCCAA ATATTTCTTT GACTTCCTAC TTTCAATTCT TTTGGGTATA TACCCAGAAG 1200
TGGAATTGCT GCGTCATATA GTAATTCCAT TTCTAATATT TTGAGGAACT GTCATACTGT 1260
TTTCCATAGC AGCCATACCA TTTTACGTCT TCAGCAGGAA TATTCAAGGT TTCCAGTTTC 1320
TCTACATCCT CTCCAACACT GTTTTCTGTT TCTTTTGTAG TAGCCATGCT AATGGGAGTG 1380
AGGTGGTATT TCATTGTAGT TTTAATTTGT ATTTTCATAC GTATATATGA AAAAATAATA 1440
TATATGAAAA AATATATTAT ACATAAAAAT ATATAATTTA TAATACATAA AATATATTAT 1500
ATATTATATA TTATACATAA AGTATATAAT ATATAATATA CATAAAATAT ATATAATATA 1560
CATAAAATAT ATAATATATT TGTATAAAAT ATGTATTATA TATTATATAT AAAATATGTA 1620
TTATATATCA TATATAAAAC ATAATATATA TTATATATAA AACATAATAT ATATTATATA 1680
TAAAACATAT AATATATAAA ACATATAATA TATATTATAT ATAAAACATA ATATATATTA 1740
TATATAAAAC ATATAATATA TATTATATAT AAAACATATA ATATATATTA TATATAAAAC 1800
ATATAATATA TATTATATAA AACATATATA TATAAAATAT ATAATATATA AAAATATATA 1860
ATATATAATA 1870
|
